{"result": "Epirubicin is a compound classified as a Topoisomerase Inhibitor, primarily used in the treatment of various types of cancer, including stomach cancer, prostate cancer, and sarcoma. This medication is associated with several side effects, which may include lactic acidosis, agranulocytosis, and abdominal distension. As a versatile treatment option, Epirubicin plays a significant role in oncology, targeting different cancer types while presenting a range of potential adverse effects that require monitoring.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"EPIRUBICIN\"\nDescription List: [\"Epirubicin is a compound classified as a Topoisomerase Inhibitor that treats Stomach Cancer.\", \"Epirubicin is a compound classified as a Topoisomerase Inhibitor used to treat prostate cancer, with side effects including lactic acidosis and agranulocytosis.\", \"Epirubicin is a topoisomerase inhibitor that treats Sarcoma, with side effects including abdominal distension and agranulocytosis.\"]\n#######\nOutput:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": 1}, "history": null}